Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology-Reference-Cited by-同舟云学术

Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Published:2021-12 Issue:12 Volume:19 Page:1441-1464
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Ganti Apar Kishor P.¹,Loo Billy W.²,Bassetti Michael³,Blakely Collin⁴,Chiang Anne⁵,D'Amico Thomas A.⁶,D'Avella Christopher⁷,Dowlati Afshin⁸,Downey Robert J.⁹,Edelman Martin¹⁰,Florsheim Charles¹¹,Gold Kathryn A.¹²,Goldman Jonathan W.¹³,Grecula John C.¹⁴,Hann Christine¹⁵,Iams Wade¹⁶,Iyengar Puneeth¹⁷,Kelly Karen¹⁸,Khalil Maya¹⁹,Koczywas Marianna²⁰,Merritt Robert E.¹⁴,Mohindra Nisha²¹,Molina Julian²²,Moran Cesar²³,Pokharel Saraswati²⁴,Puri Sonam²⁵,Qin Angel²⁶,Rusthoven Chad²⁷,Sands Jacob²⁸,Santana-Davila Rafael²⁹,Shafique Michael³⁰,Waqar Saiama N.³¹,Gregory Kristina M.³²,Hughes Miranda³²

Affiliation:

1. 1Fred & Pamela Buffett Cancer Center;

2. 2Stanford Cancer Institute;

3. 3University of Wisconsin Carbone Cancer Center;

4. 4UCSF Helen Diller Family Comprehensive Cancer Center;

5. 5Yale Cancer Center/Smilow Cancer Hospital;

6. 6Duke Cancer Institute;

7. 7Abramson Cancer Center at the University of Pennsylvania;

8. 8Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

9. 9Memorial Sloan Kettering Cancer Center;

10. 10Fox Chase Cancer Center;

11. 11Patient Advocate;

12. 12UC San Diego Moores Cancer Center;

13. 13UCLA Jonsson Comprehensive Cancer Center;

14. 14The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

15. 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

16. 16Vanderbilt-Ingram Cancer Center;

17. 17UT Southwestern Simmons Comprehensive Cancer Center;

18. 18UC Davis Comprehensive Cancer Center;

19. 19O'Neal Comprehensive Cancer Center at UAB;

20. 20City of Hope National Medical Center;

21. 21Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

22. 22Mayo Clinic Cancer Center;

23. 23The University of Texas MD Anderson Cancer Center;

24. 24Roswell Park Comprehensive Cancer Center;

25. 25Huntsman Cancer Institute at the University of Utah;

26. 26University of Michigan Rogel Cancer Center;

27. 27University of Colorado Cancer Center;

28. 28Dana Farber/Brigham and Women's Cancer Center;

29. 29Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

30. 30Moffitt Cancer Center;

31. 31Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

32. 32National Comprehensive Cancer Network.

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung Cancer (SCLC) provide recommended management for patients with SCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. This selection for the journal focuses on metastatic (known as extensive-stage) SCLC, which is more common than limited-stage SCLC. Systemic therapy alone can palliate symptoms and prolong survival in most patients with extensive-stage disease. Smoking cessation counseling and intervention should be strongly promoted in patients with SCLC and other high-grade neuroendocrine carcinomas. The “Summary of the Guidelines Updates” section in the SCLC algorithm outlines the most recent revisions for the 2022 update, which are described in greater detail in this revised Discussion text.

Publisher

Harborside Press, LLC

Subject

Oncology

Link

https://jnccn.org/downloadpdf/journals/jnccn/19/12/article-p1441.xml

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of initial check, information exchange, final accuracy check, reaction information nursing on the psychology of elderly with lung cancer;World Journal of Clinical Cases;2024-02-06

2. Effectiveness of CT radiomic features combined with clinical factors in predicting prognosis in patients with limited-stage small cell lung cancer;BMC Cancer;2024-02-03

3. Prognostic implications of neutrophil‐to‐lymphocyte ratio in patients with extensive‐stage small cell lung cancer receiving chemoimmunotherapy: A multicenter, real‐world study;Thoracic Cancer;2024-01-31

4. Incidence Rate of Occult Lymph Node Metastasis in Clinical T 1-2 N 0 M 0 Small Cell Lung Cancer Patients and Radiomic Prediction Based on Contrast-enhanced CT Imaging: A Multicentre Study;2024-01-08

5. Usefulness of baseline immature reticulocyte fraction to mature reticulocyte fraction ratio (IMR) as A prognostic predictor for patients with small cell lung cancer;Heliyon;2024-01